Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
The US is an exception but generally, the cost of therapies becomes commercially viable with the passage of time.
For example, our 2 year old daughter just had her DNA profiled because she has a few manageable, yet ongoing developmental deficiencies. Her DNA markers will guide her treatment.
When I was a child this type of treatment was sci-fi, and when it was invented you could have said “by rich for rich” or whatever.
For rich by rich, only rich get.
Now, sing with me: “Only in America…”
Thats not really true.
The US is an exception but generally, the cost of therapies becomes commercially viable with the passage of time.
For example, our 2 year old daughter just had her DNA profiled because she has a few manageable, yet ongoing developmental deficiencies. Her DNA markers will guide her treatment.
When I was a child this type of treatment was sci-fi, and when it was invented you could have said “by rich for rich” or whatever.
Despite my other comments, I suspect you are right.
Cost and price are two different things. Insulin is cheap to make but people die from not being able to afford the sticker price.
… In the US, yes
Not outside the US